Skip to main content
    N

    Neogen Corporation (NEOG)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $11.76
    +0.08 (+0.68%)

    Market Cap: $2.55B

    Last updated: Nov 06, 2026 at 4:10 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    65%(26/40)
    Avg Surprise
    +23.72%
    Streak
    6 Q

    Upcoming Estimates

    Period ending Nov 30, 2026
    EPS Consensus$0.06
    Range$0.06 - $0.07
    3 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$0.10-34.5%
    60d ago$0.09-32.2%
    30d ago$0.09-32.2%
    7d ago$0.08-20.9%
    Current$0.06
    Revenue Consensus
    $223M
    Range$222M - $223M
    4 analysts
    Period ending Feb 28, 2027
    EPS Consensus$0.08
    Range$0.07 - $0.10
    3 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$0.07+24.9%
    60d ago$0.07+13.6%
    30d ago$0.07+13.6%
    7d ago$0.07+28.2%
    Current$0.08
    Revenue Consensus
    $214M
    Range$213M - $215M
    4 analysts
    Last 12 of 40 reported quarters and 3 upcoming estimates
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    May 27EST
    		-$0.13$0.11 - $0.16--3--
    Feb 27EST
    		-$0.08$0.07 - $0.10--3
    No revisions (30d)
    		-
    Nov 26EST
    		-$0.06$0.06 - $0.07--3
    No revisions (30d)
    		-
    Aug 26
    Reported Oct 6
    		$0.07$0.04$0.04 - $0.05+75.00%Beat3
    0
    1
    30d
    		+75.0%
    May 26
    Reported Jul 30
    		$0.08$0.03$0.01 - $0.04+166.67%Beat3
    1
    0
    30d
    		+60.0%
    Feb 26
    Reported Apr 9
    		$0.09$0.05$0.04 - $0.07+80.00%Beat3
    0
    2
    30d
    		-10.0%
    Nov 25
    Reported Jan 8
    		$0.10$0.07$0.06 - $0.07+42.86%Beat3
    0
    1
    30d
    		-9.1%
    Aug 25
    Reported Oct 9
    		$0.04$0.04$0.03 - $0.05+0.00%Beat3
    No revisions (30d)
    		-42.9%
    May 25
    Reported Jul 29
    		$0.05$-0.03$-0.04 - $-0.02+266.67%Beat2
    0
    1
    30d
    		-50.0%
    Feb 25
    Reported Apr 9
    		$0.10$0.12$0.11 - $0.12-16.67%Miss2
    0
    1
    30d
    		-16.7%
    Nov 24
    Reported Jan 10
    		$0.11$0.11$0.10 - $0.11+0.00%Beat2
    0
    1
    30d
    		+0.0%
    Aug 24
    Reported Oct 10
    		$0.07$0.09$0.08 - $0.09-22.22%Miss2
    No revisions (30d)
    		-36.4%
    May 24
    Reported Jul 30
    		$0.10$0.12$0.11 - $0.12-16.67%Miss2
    No revisions (30d)
    		-28.6%
    Feb 24
    Reported Apr 9
    		$0.12$0.14$0.14 - $0.14-14.29%Miss1
    No revisions (30d)
    		+0.0%
    Nov 23
    Reported Jan 9
    		$0.11$0.14$0.14 - $0.14-21.43%Miss1
    No revisions (30d)
    		-26.7%

    Key Metrics

    Valuation
    P/E Ratio34.59EV/EBITDA27.93x
    Price/FCF51.56xFCF Yield1.94%
    Profitability
    Profit Margin-6.35%Operating Margin-0.81%
    ROE-2.67%ROIC-0.34%
    Financial Health
    Debt/Equity0.37xInterest Coverage0.84x
    Current Ratio3.90xQuick Ratio2.92x
    Trading Statistics
    Beta1.86Avg Volume3.13M
    52-Week High$14.2652-Week Low$5.37

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$12.07
    SMA 20$12.00
    SMA 50$12.25
    SMA 200$10.48
    EMA 10$11.99
    EMA 20$12.06
    EMA 50$11.98
    EMA 200$10.38

    MACD

    Line: -0.08Signal: -0.06Hist: -0.02

    ADX

    ADX: 15.3+DI: 19.7-DI: 18.6

    Aroon & PSAR

    Aroon Up8.0
    Aroon Down16.0
    PSAR$12.78

    Bollinger Bands

    Upper Band$12.52
    Lower Band$11.48
    %B Position868%(Upper)
    Band Width0.27

    RSI (14-Day)

    Neutral
    45.5

    Momentum Oscillators

    Stoch %K36.8
    Stoch %D41.3
    Williams %R-76.7
    ROC (10d)-3.5%
    Momentum-0.43
    CCI (20d)-100.6
    MFI (14d)49.7

    Volatility Measures

    ATR (14d)$0.57(4.8%)
    StdDev (20d)0.26
    Hist Vol40.5%(High)

    Volume Flow

    VWAP$11.73
    OBV115.1M
    AD Line51.4M
    CMF (20d)-0.038

    Volume Metrics

    Avg Vol (20d)2.8M
    Vol Ratio0.9x
    VWMA (20d)$12.02

    Pivot Points

    R3$13.46
    R2$13.01
    R1$12.34
    Pivot Point$11.89
    S1$11.22
    S2$10.77
    S3$10.10

    Advanced Oscillators

    TSI-4.20
    Ultimate Osc42.5
    KST-24.81

    Financial Data

    QuarterAug 2026May 2026Feb 2026Nov 2025Aug 2025May 2025Feb 2025Nov 2024Aug 2024May 2024Feb 2024Nov 2023
    Total Revenue$222.80M$225.32M$211.20M$224.69M$209.20M$225.48M$221.00M$231.26M$216.96M$236.79M$228.81M$229.63M
    Cost of Revenue$117.30M$117.47M$112.20M$118.01M$114.20M$132.63M$110.70M$117.93M$112.04M$123.31M$111.93M$112.86M
    Gross Profit$105.50M$107.85M$99.00M$106.68M$95.00M$92.84M$110.30M$113.33M$104.93M$113.48M$116.88M$116.77M
    Operating Expenses$107.30M$104.68M$102.30M$112.06M$111.10M$704.02M$104.90M$570.81M$102.67M$100.44M$104.86M$102.31M
    R&D$6.50M$4.91M$3.80M$4.56M$5.10M$6.29M$4.50M$5.11M$5.20M$5.14M$4.85M$5.76M
    SG&A$59.30M$58.70M$60.30M$65.21M$60.90M$52.96M$55.80M$57.77M$51.67M$50.96M$52.09M$51.72M
    Operating Income$-1,800,000$3.17M$-3,300,000$-5,377,000$-16,100,000$-611,173,000$5.40M$-457,484,000$2.26M$13.04M$12.02M$14.46M
    Interest Income$0$0$0$592,000$918,000$644,000$0$774,000$993,000$1.10M$1.61M$1.86M
    Interest Expense$13.80M$12.41M$13.90M$14.85M$15.50M$14.74M$17.00M$18.14M$18.61M$18.62M$18.29M$18.03M
    Income Before Tax$-14,900,000$-12,144,000$-20,300,000$-20,364,000$43.80M$-631,219,000$-9,700,000$-476,572,000$-15,609,000$-6,399,000$-5,822,000$-3,747,000
    Income Tax Expense$-3,000,000$-830,000$-3,300,000$-4,440,000$7.50M$-19,010,000$1.20M$-20,290,000$-3,000,000$-984,000$-3,800,000$-260,000
    Net Income$-11,900,000$-11,314,000$-17,000,000$-15,924,000$36.30M$-612,209,000$-10,900,000$-456,282,000$-12,609,000$-5,415,000$-2,022,000$-3,487,000
    EBITDA$29.80M$37.28M$23.00M$23.30M$90.30M$-577,608,000$37.53M$-428,296,000$32.67M$61.58M$41.36M$42.75M
    EBIT$-1,100,000$1.78M$-6,400,000$-6,108,000$59.30M$-614,708,000$7.30M$-459,205,000$2.01M$27.41M$10.85M$12.42M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about NEOG

    Government Contracts

    Gov Obligations (TTM)
    $392304
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    -63.1%
    Active Awards
    22
    New Awards (TTM)
    9
    Avg Remaining Term
    3.8 mo

    Top agency: Department of Agriculture at 100.0% of trailing twelve month obligations across 1 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    123A9426F0036Department of AgricultureFood Safety and Inspection Service$144782Apr 13, 2026
    123A9426F0018Department of AgricultureFood Safety and Inspection Service$135283Jan 14, 2026
    12639526F0332Department of AgricultureAnimal and Plant Health Inspection Service$82041Mar 25, 2026
    123A9425F0095Department of AgricultureFood Safety and Inspection Service$45400Aug 11, 2025
    1232SA25P0506Department of AgricultureAgricultural Research Service$33561Sep 29, 2025
    123A9426F0001Department of AgricultureFood Safety and Inspection Service$21870Jan 1, 2026
    12639526F0671Department of AgricultureAnimal and Plant Health Inspection Service$14638Jun 29, 2026
    123A9426F0022Department of AgricultureFood Safety and Inspection Service$1725Feb 1, 2026
    123A9426F0074Department of AgricultureFood Safety and Inspection Service$956Jun 18, 2026

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Neogen Stock Gets A Lift From Earnings Beat And Higher Fiscal 2027 Guidance

    Neogen reported better-than-expected Q1 fiscal 2027 adjusted earnings and revenue, along with increased guidance for full-year revenue and adjusted EBITDA. This positive update highlights improved gross profit...

    Simply Wall St•11/6/26•Somewhat-Bullish

    Neogen (NEOG) Up 6.7% Since Last Earnings Report: Can It Continue?

    Neogen (NEOG) shares have increased by 6.7% since its last earnings report, outperforming the S&P 500. The company reported strong Q1 fiscal 2027 results, beating revenue and earnings estimates...

    Yahoo Finance Australia•11/5/26•Somewhat-Bullish

    Neogen CSO Jeremy Yarwood sells $114,676 in stock By Investing.com

    Neogen's Chief Scientific Officer, Jeremy Yarwood, sold 9,051 shares of company stock for $114,676 on November 4, 2026, after acquiring 16,207 shares via vested restricted stock units on November 3...

    Investing.com UK•11/5/26•Neutral

    Zoetis's offer to divest Australian assets accompanies Neogen (NEOG)'s pending Genomics sale.

    Neogen Corporation (NEOG) announced that the regulatory review for its sale of the global Genomics business to Zoetis Inc. is expected to conclude in early 2027. This timeline follows Zoetis's offer to divest certain...

    Stock Titan•11/4/26•Neutral

    A 9,051-share sale at Neogen (NEOG) followed stock vesting and 7,156 shares withheld for taxes.

    Neogen's Chief Scientific Officer, Jeremy Yarwood, sold 9,051 shares of NEOG at $12.67 per share on November 4, 2026. This sale followed the vesting of 16,207 Restricted Stock Units (RSUs) on November 3, 2026...

    Stock Titan•11/4/26•Somewhat-Bearish

    NEOG Valuation and Fair Value

    P/E
    34.6x
    Forward P/E
    16.0x
    EV/EBITDA
    27.9x
    P/FCF
    51.6x
    PEG
    0.7x
    P/B
    1.2x
    See GNG's fair value

    NEOG Profitability: Margins, ROIC and FCF

    Gross margin
    47.4%
    Operating margin
    -0.8%
    Net margin
    -6.3%
    ROIC
    -0.3%
    ROE
    -2.7%
    FCF yield
    1.9%

    NEOG Competitors

    CompanyTicker
    Maravai Lifesciences Holdings IncMRVI
    Xencor IncXNCR
    Warby Parker IncWRBY
    Guardian Pharmacy Services, Inc.GRDN
    Progyny IncPGNY
    HUTCHMED DRCHCM
    Regencell Bioscience Holdings LtdRGC
    TransMedics Group IncTMDX

    Sector: Healthcare

    NEOG Analyst Ratings

    Consensus
    Buy
    Analysts
    4
    Strong Buy
    2
    Buy
    1
    Hold
    1
    Sell
    0
    Strong Sell
    0

    NEOG Bull Case vs Bear Case

    Bear case

    • NEOG has a -6.3% net profit margin.

    NEOG Earnings: Beat Rate and Next Report

    Beat rate
    5 of 8 quarters (62.5%)
    Average surprise
    76.8%
    EPS estimate (fiscal period ending Nov 30, 2026)
    $0.06
    Estimate revisions (30 days, fiscal period ending Nov 30, 2026)
    0 up, 0 down

    NEOG Earnings Date

    NEOG reports Jan 6, 2027. The date is estimated.

    NEOG Earnings Call

    The latest NEOG earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    NEOG ETF Holders

    GNG tracks 12 ETFs that hold NEOG. The largest weights:

    1. State Street SPDR S&P Health Care Equipment ETF (XHE), 1.56% of the fund
    2. iShares Core S&P Small-Cap ETF (IJR), 0.16% of the fund
    3. Vanguard Morningstar Small-Cap Value ETF (VBR), 0.06% of the fund
    4. Vanguard Extended Market Index Fund ETF Shares (VXF), 0.06% of the fund
    5. iShares Russell 2000 ETF (IWM), 0.04% of the fund
    Open the ETF Stock Exposure tool for NEOG

    See insider activity

    Frequently Asked Questions About NEOG

    When does NEOG report earnings?

    Neogen Corporation (NEOG) is expected to report earnings on Jan 6, 2027.

    Does NEOG pay dividends?

    Neogen Corporation (NEOG) does not currently pay a regular dividend.

    What is NEOG's P/E ratio?

    Neogen Corporation has a price-to-earnings (P/E) ratio of 34.59.

    What is NEOG's market cap?

    Neogen Corporation (NEOG) has a market capitalization of $2.55B with a current stock price of $11.76.

    Related stocks

    Sector: Healthcare

    All stocks starting with N

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In